Why docosapentaenoic acid is not included in the Omega-3 Index
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Prostaglandins, Leukotrienes and Essential Fatty Acids
- Vol. 135, 18-21
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Plasma n-3 polyunsaturated fatty acids in chronic heart failure in the GISSI-Heart Failure Trial: Relation with fish intake, circulating biomarkers, and mortalityAmerican Heart Journal, 2013
- Changes in Erythrocyte Membrane Trans and Marine Fatty Acids between 1999 and 2006 in Older AmericansThe Journal of Nutrition, 2012
- A short-term n-3 DPA supplementation study in humansEuropean Journal of Nutrition, 2012
- Orally administered [14C]DPA and [14C]DHA are metabolised differently to [14C]EPA in ratsBritish Journal of Nutrition, 2012
- (n-3) Fatty Acids and Cardiovascular Health: Are Effects of EPA and DHA Shared or Complementary?The Journal of Nutrition, 2012
- Red blood cell omega-3 fatty acid levels and markers of accelerated brain agingNeurology, 2012
- Blood Eicosapentaenoic and Docosahexaenoic Acids Predict All-Cause Mortality in Patients With Stable Coronary Heart DiseaseCirculation: Cardiovascular Quality and Outcomes, 2010
- Short-term docosapentaenoic acid (22 : 5n-3) supplementation increases tissue docosapentaenoic acid, DHA and EPA concentrations in ratsBritish Journal of Nutrition, 2009
- Erythrocyte fatty acid profiles can predict acute non-fatal myocardial infarctionBritish Journal of Nutrition, 2009
- Dietary validation of a new Australian food-frequency questionnaire that estimates long-chainn-3 polyunsaturated fatty acidsBritish Journal of Nutrition, 2008